Bay Harbor Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bay Harbor Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.48K	Buy	12 +2	+20%	+$1.36K	﹤0.01%	340
2026 Q1	$7.73K	Buy	10 +2	+25%	+$1.53K	﹤0.01%	272
2025 Q4	$6.17K	Buy	8 +6	+300%	+$4.08K	﹤0.01%	247
2025 Q3	$1.12K	Buy	2 +1	+100%	+$565	﹤0.01%	495
2025 Q2	$525	Buy	+1	New	+$558	﹤0.01%	625
2020 Q4	–	Sell	-63	Closed	-$35K	–	453
2020 Q3	$35K	Buy	63 +10	+19%	+$6.06K	0.02%	183
2020 Q2	$33K	Sell	53 -27	-34%	-$15.3K	0.02%	184
2020 Q1	$39K	Buy	80 +67	+515%	+$27.6K	0.02%	150
2019 Q4	$5K	Buy	13 +7	+117%	+$2.35K	﹤0.01%	254
2019 Q3	$2K	Hold	6	–	–	﹤0.01%	308
2019 Q2	$2K	Hold	6	–	–	﹤0.01%	307
2019 Q1	$2K	Buy	+6	New	+$2.47K	﹤0.01%	346

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bay Harbor Wealth Management's REGN Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 20% in Q2 2026, buying an estimated $1.36K and bringing the position to 12 shares worth $7.48K. The position accounts for ﹤0.01% of the portfolio, ranked #340.

Bay Harbor Wealth Management first reported a position in REGN in Q1 2019 and has held it in 12 quarters since. The position peaked at $39K in Q1 2020. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Bay Harbor Wealth Management held 12 shares of Regeneron Pharmaceuticals worth $7.48K as of Q2 2026.
Bay Harbor Wealth Management bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
Regeneron Pharmaceuticals made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #340 holding.
Bay Harbor Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 12 quarters since.
Bay Harbor Wealth Management's Regeneron Pharmaceuticals position peaked at $39K in Q1 2020.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.